BioDulse: The Effect of an Irish Seaweed Protein Extract on Glucose Control in Healthy Adults

University of Limerick

Status: Completed

Conditions: Healthy

Treatments: Dietary Supplement: Seaweed protein

Study type: Interventional

Funder types: Other

Identifiers

NCT05850429

2022_12_14_EHS

Details and patient eligibility

About

Co-ingesting protein with carbohydrate is an effective way to improve postprandial glucose handling. The investigators have isolated and identified a bioactive protein extracted from seaweed. The investigators aim to explore how varying doses of seaweed protein influence postprandial glycaemia and insulinaemia in a healthy population.

Enrollment: 11 patients

Sex: All

Ages: 18 to 67 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Aged 18-67

Exclusion criteria

• Terminal disease
• Past medical history of vascular disease, cancer, diabetes, neurological, kidney, pulmonary, digestive (Coeliac disease), thyroidal disease, cognitive impairment;
• Exclusively receiving enteral or parenteral nutrition,
• Any conditions/anomalies that are contraindications to bioelectrical impedance analysis as per institutional risk assessment and SOP.

Trial design

Primary purpose: Basic Science

Allocation: Randomized

Interventional model: Crossover Assignment

Masking: Double Blind

---

11 participants in 3 patient groups, including a placebo group

Control

Placebo Comparator group

Description:

0.6g/kg body mass maltodextrin in solution.

Treatment:

Dietary Supplement: Seaweed protein

Low protein

Experimental group

Description:

0.6g/kg body mass maltodextrin PLUS 0.075g/kg body mass protein from Biodulse, in solution

Treatment:

Dietary Supplement: Seaweed protein

Medium protein

Experimental group

Description:

0.6g/kg body mass maltodextrin PLUS 0.15g/kg body mass protein from Biodulse, in solution

Treatment:

Dietary Supplement: Seaweed protein